Impetigo

• FDA approval · 2025-05-13
  FDA Approved: MUPIROCIN — Original Application (Encube Ethicals, Inc.)

  FDA approves Encube Ethicals, Inc.'s original application for mupirocin topical antibiotic (generic mupirocin).

• FDA approval · 2024-07-08
  FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved a supplemental application for Mupirocin by Glenmark Pharmaceuticals Inc., USA.

• FDA approval · 2023-03-03
  FDA Approved: MUPIROCIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

  The FDA approved a supplemental application for mupirocin from Padagis Israel Pharmaceuticals Ltd.

• FDA approval · 2022-11-15
  FDA Approved: MUPIROCIN — Original Application (Amneal Pharmaceuticals NY LLC)

  FDA approved the original application for mupirocin from Amneal Pharmaceuticals NY LLC (generic mupirocin).

• FDA approval · 2021-11-16
  FDA Approved: MUPIROCIN — Original Application (Alembic Pharmaceuticals Inc.)

  The FDA approved Alembic Pharmaceuticals' original ANDA for mupirocin topical ointment, authorizing its marketing as a generic antibiotic fo…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2021-08-04
  FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark Pharmaceuticals Inc., USA's supplemental application for mupirocin.

• FDA approval · 2020-04-27
  FDA Approved: MUPIROCIN — Original Application (NORTHSTAR RX LLC)

  FDA approved the original application for mupirocin calcium (Mupirocin) by NorthStar RX LLC, enabling a generic topical antibiotic for skin …

• FDA approval · 2019-07-16
  FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved a supplemental application for Mupirocin from Glenmark Pharmaceuticals Inc., USA. This approval updates the existing ANDA produ…

• FDA approval · 2018-10-30
  FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark Pharmaceuticals Inc., USA's supplemental application for mupirocin (generic topical ointment) under ANDA 201587. This …

• FDA approval · 2016-12-06
  FDA Approved: MUPIROCIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved a supplemental application for mupirocin by Padagis Israel Pharmaceuticals Ltd.

• FDA approval · 2016-01-05
  FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark's supplemental application for a generic mupirocin product (ANDA 090480).

• FDA approval · 2015-12-30
  FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved a supplemental application for mupirocin (generic) from Glenmark Pharmaceuticals Inc., USA, related to an existing ANDA.

• FDA approval · 2015-11-18
  FDA Approved: MUPIROCIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA has approved a supplemental application for mupirocin from Sun Pharmaceutical Industries, Inc., signaling an approved change related to …

• FDA approval · 2013-01-24
  FDA Approved: MUPIROCIN — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark's original ANDA for mupirocin topical antibiotic, enabling a generic version to be marketed. The approval confirms the…

• FDA approval · 2011-06-08
  FDA Approved: MUPIROCIN — Original Application (Glenmark Pharmaceuticals Inc., USA)

  The FDA approved Glenmark's generic mupirocin (ANDA 090480). The approval covers its topical antibiotic use for impetigo and intranasal use …

• FDA approval · 2010-12-20
  FDA Approved: CEPHALEXIN — Original Application (AvPAK)

  FDA approved the original application for Cephalexin (generic) from AvPAK under ANDA090836.